 |
市場調查報告書
商品編碼
2076155
施馬倫貝格病毒治療市場：依治療方法、目標動物、最終使用者和地區分類。Schmallenberg Virus Treatment Market, By Treatment Type, By Animal Type, By End User, By Geography |
||||||
預計到 2026 年，施馬倫貝格病毒治療市場價值將達到 1.403 億美元，到 2033 年將達到 2.5 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.6%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 1.403億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 8.60% | 2033年市場規模預測： | 2.5億美元 |
施穆倫貝格病毒是一種主要感染歐洲反芻動物的病原體，其名稱源自於2011年首次發現該病毒的德國小鎮施穆倫貝格。該病毒主要透過蠓屬（Cyricoides）的昆蟲傳播，這些昆蟲是病毒擴散的媒介。牛、羊、山羊等牲畜感染後通常會出現輕度至中度症狀，包括發燒、產乳量下降和繁殖能力降低。在懷孕動物中，尤其是牛，該病毒會導致牛和羔羊出現先天性畸形和死胎，對畜牧業構成重大威脅。施穆倫貝格病毒已傳播至歐洲多個國家，由於生產力下降和繁殖問題，受感染的農場遭受了經濟損失。目前尚無針對動物的特異性治療方法，但預防和控制措施包括盡可能控制傳播媒介昆蟲，並在一些地區實施疫苗接種計畫。值得注意的是，病毒主要感染動物，對人類健康的風險不大。目前的研究工作正在進行中，重點是了解病毒及其傳播機制，並開發更有效的疫苗和應對措施，以保護畜牧業和農業免受其影響。
施馬倫貝格病毒的預防和控制措施包括多種，例如控制傳播媒介以減少蠓蟲的叮咬，在可行的情況下實施疫苗接種計劃，以及密切監測牲畜的感染徵兆。值得強調的是，該病毒主要感染動物，對人類健康不構成重大風險。目前的研究重點在於闡明該病毒及其傳播動力學，並開發更有效的疫苗和控制策略，以減輕其對歐洲畜牧業和農業部門的影響。
市場動態：
預計在預測期內，新的疫情爆發、公眾意識的提高以及研發投入將推動全球施馬倫伯格病毒治療市場的成長。此外，各項支持措施預計也將促進該市場的成長。疫苗研發、抗病毒藥物、輔助療法和診斷工具的進步預計將在預測期內為全球施馬倫伯格病毒治療市場創造成長機會。
然而，治療選擇有限、疫苗研發複雜以及經濟獎勵不足預計將在預測期內阻礙施馬倫貝格病毒治療市場的成長。
本研究的主要特點：
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數分析了施馬倫貝格病毒治療市場的主要參與者：公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 施馬倫貝格病毒治療市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以利用施馬倫貝格病毒治療市場分析中使用的各種策略矩陣來促進決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 新出現的感染疾病
- 意識
- 研究與開發
- 支持措施
- 抑制因子
- 治療選擇有限
- 疫苗研發的複雜性
- 機會
- 疫苗研發
- 抗病毒藥物
- 支持性護理解決方案
- 診斷工具
- 促進因素
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特五力分析
- 併購情景
- 供給面和需求面分析
- 經濟影響
第5章：施馬倫貝格病毒治療市場：依治療類型分類，2021-2033年
- 抗病毒藥物
- 抗發炎藥
- 止痛藥
- 疫苗
- 其他
第6章：施馬倫貝格病毒治療市場：依動物類型分類，2021-2033年
- 牛
- 羊
- 山羊
- 其他
第7章：施馬倫貝格病毒療法市場：依最終用戶分類，2021-2033年
- 獸醫醫院和診所
- 研究機構
- 獸藥局和藥局
- 其他
第8章：施馬倫貝格病毒治療市場：按地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 中東和非洲
- GCC
- 以色列
- 北非
- 中非
- 其他中東和非洲國家
第9章 競爭情勢
- Boehringer Ingelheim
- Zoetis
- MSD Animal Health（Merck Animal Health）
- Elanco Animal Health
- Ceva Sante Health
- Virbac
- Bayer Animal Health
- Vetoquinol
- Huvepharma
- IDT Biologika
- Heska Corporation
- Dechra Pharmaceuticals
- Phibro Animal Health
- Nogen Corporation
第10章
- 調查方法
- 關於本公司
Schmallenberg Virus Treatment Market is estimated to be valued at USD 140.3 Mn in 2026 and is expected to reach USD 250.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 140.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.60% | 2033 Value Projection: | USD 250.0 Mn |
Schmallenberg virus is a pathogen that primarily affects ruminant livestock in Europe, with its name derived from the German town where it was first identified in 2011. This virus is mainly transmitted by Culicoides midges, which serve as vectors for its spread. When livestock, such as cattle, sheep, and goats, are infected, they often display mild to moderate symptoms, including fever, reduced milk production, and decreased fertility. In pregnant animals, particularly cows and ewes, the virus can lead to congenital malformations in the offspring and stillbirths, posing a significant threat to livestock production.The Schmallenberg virus has extended its reach to various European countries, causing economic losses for affected farms due to reduced productivity and reproductive issues. While there is no specific treatment for the virus in animals, prevention and control strategies involve vector control, when possible, as well as vaccination programs in some regions. Notably, the virus primarily affects animals and is not considered a substantial risk to human health. Ongoing research efforts continue to focus on understanding the virus, its transmission dynamics, and the development of more effective vaccines and control measures to safeguard livestock and the agricultural industry from its impact.
Preventing and controlling the Schmallenberg virus involves various measures, including vector control to limit midge exposure, vaccination programs where available, and vigilant monitoring for signs of infection in livestock. It's worth emphasizing that the virus primarily affects animals and does not pose a significant risk to human health. Ongoing research efforts are dedicated to better understanding the virus, its transmission dynamics, and the development of more effective vaccines and control strategies to mitigate its impact on livestock and the agricultural sector in Europe.
Market Dynamics:
Emerging outbreaks, growing awareness, and research and development are anticipated to drive growth of the global Schmallenberg virus treatment market over the forecast period. Moreover, supportive measures are also expected to boost the growth of the global Schmallenberg virus treatment market over the forecast period. Vaccine development, antiviral drugs, supportive care solutions and diagnostic tools are expected to create growth opportunities for the global Schmallenberg virus treatment market during the forecast period.
However, limited treatment options, the complexity of vaccine development, and low economic incentives are expected to hamper growth of the Schmallenberg virus treatment market over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the Schmallenberg virus treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Boehringer Ingelheim, Zoetis, MSD Animal Health (Merck Animal Health), Elanco Animal Health, Ceva Sante Animale, Virbac, Bayer Animal Health, Vetoquinol, Huvepharma, IDT Biologika, Heska Corporation, Dechra Pharmaceuticals, Phibro Animal Health, Neogen Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The Schmallenberg virus treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Schmallenberg virus treatment market
Schmallenberg Virus Treatment Market Detailed Segmentation:
- By Treatment Type (Revenue, USD Mn, 2021 - 2033)
- Antiviral Drugs
- Anti-inflammatory Drugs
- Analgesics
- Vaccines
- Others
- By Animal Type (Revenue, USD Mn, 2021 - 2033)
- Cattle
- Sheep
- Goats
- Others
- By End User (Revenue, USD Mn, 2021 - 2033)
- Veterinary Hospitals and Clinics
- Research Institutions
- Veterinary Pharmacies and Drug Store
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profile:
- Boehringer Ingelheim
- Zoetis
- MSD Animal Health (Merck Animal Health)
- Elanco Animal Health
- Ceva Sante Animale
- Virbac
- Bayer Animal Health
- Vetoquinol
- Huvepharma
- IDT Biologika
- Heska Corporation
- Dechra Pharmaceuticals
- Phibro Animal Health
- Neogen Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Schmallenberg Virus Treatment , By Treatment Type
- Market Schmallenberg Virus Treatment , By Animal Type
- Market Schmallenberg Virus Treatment , By End User
- Market Schmallenberg Virus Treatment, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Emerging Outbreaks
- Growing Awareness
- Research and Development
- Supportive Measures
- Restraints
- Limited Treatment Options
- Complexity of Vaccine Development
- Opportunities
- Vaccine development
- Antiviral Drugs
- Supportive Care Solutions
- Diagnostic Tools
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
- Supply Side and Demand Side Analysis
- Economic Impact
5. Schmallenberg Virus Treatment Market , By Treatment Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Antiviral Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Schmallenberg Virus Treatment Market, By Animal Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Goats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
7. Schmallenberg Virus Treatment Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Veterinary Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Veterinary Pharmacies and Drug Store
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
8. Schmallenberg Virus Treatment Market , By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 €"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
- GCC
- Israel
- North Africa
- Central Africa
- Rest of Middle East & Africa
9. Competitive Landscape
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zoetis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MSD Animal Health (Merck Animal Health)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ceva Sante Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vetoquinol
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Huvepharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IDT Biologika
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Heska Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dechra Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Phibro Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nogen Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
全球寵物保健市場規模、佔有率、趨勢和成長分析報告（2026-2034）
寵物健康與營養快速消費品市場預測至2034年－按產品類型、寵物品種、原料類型、分銷管道和最終用戶分類的全球分析寵物情緒健康評估市場預測至2034年：按動物種類、技術、應用、最終用戶和地區分類的全球分析
動物血糖監測市場分析與預測（至2035年）：依產品、技術、組件、應用、最終使用者、功能、解決方案、設備類型、目標動物及使用方法
獸醫保健市場規模、佔有率和成長分析：按動物類型、服務類型、產品類型、應用、最終用戶和地區分類－2026-2033年產業預測
獸醫自體免疫疾病治療市場：市場機會、成長要素、產業趨勢分析及2026-2035年預測寵物健康資料平台市場預測至2034年－全球分析（按平台類型、組件、資料類型、目標動物、整合生態系統、經營模式、應用、最終用戶和地區分類）寵物心理健康市場預測至2034年－按產品類型、適應症、動物種類、通路和地區分類的全球分析多通道動物麻醉設備市場預測至 2034 年—按類型、目標動物、應用和地區進行全球分析。
動物用藥品活性成分市場：依動物種類、產品類型、化合物類型、原料、應用及最終用戶分類－2026-2032年全球市場預測